BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

GILDER GAGNON HOWE & CO LLC's Holding History (CIK: 0000902464)

Note: Option positions (PUT/CALL) are excluded.

Q3 2022

Shares 303,642 Value ($000) $3,826 Avg Close $12.87 Range $10.33 - $15.43

Q2 2022

Shares 305,157 Value ($000) $3,229 Avg Close $10.32 Range $7.61 - $18.00

Q1 2022

Shares 339,009 Value ($000) $5,512 Avg Close $16.04 Range $11.56 - $19.99

Q4 2021

Shares 340,779 Value ($000) $4,720 Avg Close $13.23 Range $10.72 - $15.77

Q3 2021

Shares 313,806 Value ($000) $4,509 Avg Close $15.77 Range $14.00 - $18.48

Q2 2021

Shares 313,393 Value ($000) $4,955 Avg Close $13.59 Range $9.23 - $17.74

Q1 2021

Shares 211,407 Value ($000) $2,150 Avg Close $10.31 Range $7.27 - $14.24

Q3 2020

Shares 592,200 Value ($000) $2,034 Avg Close $4.29 Range $3.30 - $6.03

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2022	303,642	$3,826	$12.87	$10.33 - $15.43
Q2 2022	305,157	$3,229	$10.32	$7.61 - $18.00
Q1 2022	339,009	$5,512	$16.04	$11.56 - $19.99
Q4 2021	340,779	$4,720	$13.23	$10.72 - $15.77
Q3 2021	313,806	$4,509	$15.77	$14.00 - $18.48
Q2 2021	313,393	$4,955	$13.59	$9.23 - $17.74
Q1 2021	211,407	$2,150	$10.31	$7.27 - $14.24
Q3 2020	592,200	$2,034	$4.29	$3.30 - $6.03